Home
>
National Drug Code (NDC)
>
Gaviscon
Gaviscon - 0135-0096-26 - (aluminum hydroxide and magnesium trisilicate)
Drug Information of Gaviscon
| Product NDC: | 0135-0096 |
| Proprietary Name: | Gaviscon |
| Non Proprietary Name: | aluminum hydroxide and magnesium trisilicate |
| Active Ingredient(s): | 80; 14.2 mg/1; mg/1 & nbsp; aluminum hydroxide and magnesium trisilicate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, CHEWABLE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Gaviscon
| Product NDC: | 0135-0096 |
| Labeler Name: | GlaxoSmithKline Consumer Healthcare LP |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA018685 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110613 |
Package Information of Gaviscon
| Package NDC: | 0135-0096-26 |
| Package Description: | 100 TABLET, CHEWABLE in 1 BOTTLE (0135-0096-26) |
NDC Information of Gaviscon
| NDC Code | 0135-0096-26 |
| Proprietary Name | Gaviscon |
| Package Description | 100 TABLET, CHEWABLE in 1 BOTTLE (0135-0096-26) |
| Product NDC | 0135-0096 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | aluminum hydroxide and magnesium trisilicate |
| Dosage Form Name | TABLET, CHEWABLE |
| Route Name | ORAL |
| Start Marketing Date | 20110613 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline Consumer Healthcare LP |
| Substance Name | ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE |
| Strength Number | 80; 14.2 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |
